CureMatch
×
  • Physicians
  • BioPharma
  • Employers
  • News
  • Clinical Order
  • About Us
  • Login
Greg Simon

Greg Simon

Cancer Moonshot

Mr. Simon has held senior positions in both chambers of Congress, served in two Presidential administrations, was a senior strategy consultant to a variety of international technology CEO’s, co-founded with Michael Milken, and led, FasterCures, co-founded and led the Melanoma Research Alliance, was the Senior Vice President at Pfizer for Worldwide Policy and Patient Engagement, and was the CEO of Poliwogg, a financial services company creating unique capital market opportunities and indexes in healthcare and life sciences. He has developed a reputation as a visionary strategist, a dynamic public speaker and writer, and as an expert analyst of emerging trends in healthcare, information technology, innovative drug research and development, and patient advocacy.

Most recently, Greg was the President of the Biden Cancer Initiative, a nonprofit formed by Vice President Joe Biden and Dr. Jill Biden to continue the work of the White House Cancer Moonshot to double the rate of progress in preventing, detecting, diagnosing, treating, and surviving cancer. He came to that position after serving as the Executive Director of the White House Cancer Moonshot Task Force established by President Barack Obama and led by Vice President Biden. Greg and his team helped launch over seventy innovative private and public-private collaborations and numerous novel interagency and international initiatives that helped support the successful effort to secure $1.8 billion in new funding for the Cancer Moonshot.

He received his law degree from the University of Washington in 1983 where he was a member of the Law Review and the Moot Court. He has a BA in history from the University of Arkansas and studied at the Institute for European Studies at the University of Vienna, Austria.

logo

+1 (858) 215-1313

Quick Links

  • Home
  • Physicians
  • About CureMatch
  • News and Latest Posts
  • Contact Us
  • FAQ

Latest News and Results

  • Launch of CureMatch Certified Precision Oncology Recognition Award May 8

    CureMatch, a leader in precision oncology, is proud to announce the establishment of the CureMatch...

  • CureMatch Announces Collaboration with Mark Cuban Cost Plus Drug Company to Promote Affordable Cancer Treatment Oct 7

    CureMatch, Inc., a healthcare technology company using precision medicine support for oncology, is proud to...

  • CureMatch Joins CancerX to Help Advance Innovative Cancer Treatments Jun 28

    CureMatch, Inc., a healthcare technology company leveraging Knowledge Representation & Reasoning (KRR) AI for precision...

© 2025 CureMatch, Inc. CureMatch is a registered trademark.
Terms of Use | Privacy Policy | HIPAA Notice

Please fill out the information below and a CureMatch representative will reach out to you.

 

Physician Request

  • This field is for validation purposes and should be left unchanged.

 

We value and respect your privacy and will not publish, share, or sell your contact information.

View Privacy Policy

Some pages of this website are intended for healthcare professionals

This webpage is strictly reserved for healthcare professionals. Please confirm that you are a healthcare professional.

Otherwise, you will be redirected to the institutional part of this website.

Thank you for your understanding.

I am a healthcare professionalI am not a healthcare professional

Get ready to utilize the latest genomics data in your practice

Rank the most promising systemic therapies for your patients

Do you need to filter out those therapies with poor outcomes

Sort through 4.5 million expertly curated combinations of drugs

Compute your own drug choices alongside CureMatch data